跳至主要内容
临床试验/NCT04387136
NCT04387136已完成4 期

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

University of Minnesota1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2020年10月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
53
试验地点
1
主要终点
Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival

研究概览

简要总结

The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.

详细描述

This is a level I randomized prospective outcomes study comparing two groups of patients. Within 15-30 minutes of planned wake-up Group 1 will receive 30 mcg of sublingual sufentanil and group 2 will not receive sublingual sufentanil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients undergoing outpatient ambulatory surgery undergoing general anesthesia for orthopedic surgery

排除标准

  • non-english speaking patients
  • patients who have allergy or intolerance to the study drugs or derivatives

研究组 & 干预措施

Sublingual Sufentanil

Experimental

Participants in this arm will receive the intervention.

干预措施: Sublingual Sufentanil (Drug)

结局指标

主要结局

Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival

时间窗: 2 hours

Pain is assessed on a scale of 0-10 (whole numbers). A score of 0 being no pain, 10 being maximum imaginable pain. Data collected upon arrival to Post-Anesthesia Care Unit (PACU).

次要结局

  • OBAS Score(2 hours)
  • Opioid Use in Recovery Room(2 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验